Anastasia V Benoit, M.D. Dermatology - MOHS-Micrographic Surgery Medicare: Accepting Medicare Assignments Practice Location: 905 W 124th Ave Ste 170, Westminster, CO 80234 Phone: 303-442-6647 Fax: 303-442-2696 |
Lawrence Fred Barfield, DO Dermatology - Procedural Dermatology Medicare: Not Enrolled in Medicare Practice Location: 10359 Federal Blvd, Suite 210, Westminster, CO 80260 Phone: 303-404-0200 Fax: 303-404-2828 |
Dr. Carol Ann Alonso, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 905 W 124th Ave Ste 170, Westminster, CO 80234 Phone: 303-442-6647 |
Dr. Jessica Olander, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 905 W 124th Ave Ste 170, Westminster, CO 80234 Phone: 303-442-6647 Fax: 303-442-2696 |
Dr. Monica Rose Boyle, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9101 Harlan St, Suite 155, Westminster, CO 80031 Phone: 303-426-5000 |
Sheila Rose Boyle, Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9101 Harlan St, Ste 155, Westminster, CO 80031 Phone: 303-426-5000 |
News Archive
This surprising finding is presented by American, Swedish, and Dutch scientists in a study being published today in the prestigious journal American Journal of Human Genetics.
Affymetrix, Inc. today launched the GeneChip miRNA 2.0 Array. This enhanced version of its best-in-class microRNA interrogation solution will support the research community's pursuit of personalized medicine by accelerating the identification of biomarkers and gene expression signatures associated with disease.
A failing heart's effect on the short-term memory. The impact of telephone interventions on behaviors in Latinos. Depression and heart disease. Risk factors contributing to premature coronary atherosclerosis in premenopausal women. These are just a few of the research findings that will be presented by faculty members of the UCLA School of Nursing at the American Heart Association's Scientific Sessions, being held November 12 - 16 in Orlando, FL.
ArtVentive Medical Group, Inc. announced today that the Company has conducted its First Human Clinical Study with its EOS Peripheral vascular occlusion device.
› Verified 2 days ago